The first company to advance a fully AI-designed molecule into human clinical trials
Exscientia uses a "patient-first" AI approach. They test drugs on actual patient tissue samples and use AI to analyze the results, ensuring the medicine works for real people, not just in lab simulations.
### Precision Drug Design
* **Centaur Chemist**: An AI platform that automates the design, synthesis, and testing cycle of new chemical compounds.
* **Precision Oncology**: Matches the right cancer drug to the right patient by analyzing cellular responses to various treatments.
* **End-to-End Discovery**: Shortens the drug discovery phase from years to months through massive parallel simulation.
**Best for**: Pharmaceutical researchers and oncology clinics focused on personalized cancer treatment.